Trump Administration Expands Fertility Treatment Coverage
The Trump administration has announced a deal with EMD Serono to lower drug prices, aiming to improve affordability for fertility services.
As part of this plan, the administration has several key components, including:
- Lowering drug prices with EMD Serono
- New benefits rules to encourage employers to offer in vitro fertilization coverage outside of health insurance
- A Food and Drug Administration priority review voucher for another fertility drug not currently available in the U.S.
EMD Serono is the third drugmaker to partner with the president, following recent announcements with Pfizer and AstraZeneca.
No direct quote available in the given text.
Author's summary: Trump expands fertility treatment coverage with new pharma deal.
More News
- Evil hamsters and the worst day of your life in the new film If I Had Legs I'd Kick You
- 'Saipan' Release Date Announced As Blockbuster Trailer Drops | Balls.ie
- Four Oakland County school districts awarded over $6 million for electric buses
- First Non-Travel Case of Monkeypox Hits California — How Does the Virus Spread?
- Grey’s Anatomy’ Just Benched a Main Character & They Won't Be Back for a While
- Pat Freiermuth Downplays Redemption Game: 'It's All About the Team'
- What's behind the surge in moose-vehicle collisions in Northern Michigan?
- Oct. 17, 2025: Where Hickenlooper won't budge; Remembering Susan Stamberg | Colorado Public Radio
- Armenians in Jerusalem and the dilemma of Israel's recognition of the Armenian Genocide
- Weekend preview: Ferrari chasing titles in ELMS, Le Mans Cup, GT Open and Asia